Research shows that riboflavin (vitamin B2) can lower blood pressure in people carrying a specific genetic variant called MTHFR 677TT, according to Gram Research analysis of randomized trials. This gene-nutrient interaction is particularly important for populations in Guatemala (up to 66% carry the variant), Mexico (32-44%), and Northern China (24%), where a precision nutrition approach targeting riboflavin and folate deficiency could reduce hypertension risk independently of blood pressure medications.

According to Gram Research analysis, folate and riboflavin, two B vitamins, may help control blood pressure, especially for people with a specific genetic variation. A new review in Biochimie shows that certain populations, particularly in Guatemala, Mexico, and China, carry a genetic change that makes them more vulnerable to high blood pressure. The good news: taking riboflavin (vitamin B2) supplements may counteract this genetic risk by helping the body use folate more effectively. This personalized nutrition approach could offer a simple, natural way to prevent high blood pressure in millions of people worldwide who have this genetic variation.

Key Statistics

A 2026 review in Biochimie found that riboflavin supplementation lowered blood pressure in individuals with the MTHFR 677TT genetic variant, independent of antihypertensive medications, based on evidence from randomized controlled trials.

According to UK Biobank evidence reviewed in 2026, folate deficiency is implicated in hypertension, the major risk factor contributing to mortality worldwide, with up to 66% of people in Guatemala carrying the high-risk MTHFR 677TT genetic variant.

A 2026 research review found that approximately 15% of pregnancies are affected by hypertension, which increases stroke risk in mothers and long-term disease risk in children, highlighting the importance of precision nutrition approaches for at-risk populations.

Riboflavin deficiency is highly prevalent worldwide, particularly in women, yet remains typically overlooked in health and research settings, according to a 2026 review examining one-carbon metabolism and blood pressure control.

The Quick Take

  • What they studied: How two B vitamins (folate and riboflavin) affect blood pressure, especially in people with a specific genetic change that makes them prone to high blood pressure
  • Who participated: This is a review article that examined existing research rather than conducting a new study with participants. The findings apply to populations worldwide, with the highest genetic risk in Guatemala (up to 66% of people), Mexico (32-44%), and Northern China (24%)
  • Key finding: Riboflavin supplements lowered blood pressure in people with the MTHFR 677TT genetic variant, independent of blood pressure medications, according to randomized trials reviewed
  • What it means for you: If you have family roots in Guatemala, Mexico, or Northern China, or if you have high blood pressure that’s hard to control, getting enough riboflavin and folate might help. Talk to your doctor about genetic testing and whether B vitamin supplements could be right for you

The Research Details

This is a review article, meaning the authors examined and summarized existing scientific research rather than conducting their own experiment. They looked at clinical studies and genome-wide association studies, which are large genetic databases that help scientists find connections between genes and diseases. The researchers focused on how folate and riboflavin work in the body’s one-carbon metabolism, a chemical process that affects many health functions including blood pressure control.

The review specifically examined a genetic variation called the C677T polymorphism in the MTHFR gene. This gene controls an enzyme that processes folate, and the variation changes how well this enzyme works. The authors also reviewed randomized controlled trials, which are the gold standard in medical research, showing that riboflavin supplements can lower blood pressure in people with this genetic variation.

This approach is called precision nutrition, meaning tailoring nutritional recommendations to a person’s individual genetic makeup rather than giving everyone the same advice.

Understanding how genes and nutrients interact is important because it explains why the same diet or supplement works differently for different people. This research matters because high blood pressure affects millions worldwide and is a leading cause of death. By identifying specific genetic groups that respond to riboflavin, doctors could offer targeted prevention strategies. This is especially important for pregnant women, since high blood pressure during pregnancy can harm both mother and baby and increase stroke risk later in life

This is a review article published in a peer-reviewed scientific journal, meaning other experts checked the work before publication. The authors cite evidence from randomized controlled trials, which are considered high-quality evidence. However, because this is a review rather than a new study, the strength of conclusions depends on the quality of the studies reviewed. The authors note that more research is needed to fully understand the mechanisms involved. The findings are particularly strong for riboflavin’s effect in people with the TT genetic variant, based on multiple randomized trials

What the Results Show

Research shows that riboflavin (vitamin B2) can lower blood pressure in people who carry the MTHFR 677TT genetic variant. This effect occurred independently of blood pressure medications, meaning it worked even in people already taking drugs to control their blood pressure. The genetic variant changes how the body processes folate, and riboflavin acts as a helper molecule that makes folate metabolism work better.

The UK Biobank, a massive database of health information from hundreds of thousands of people, found evidence linking folate deficiency to high blood pressure. This connection is particularly important because folate deficiency is common worldwide, especially in women. The research suggests that optimizing folate levels through better nutrition or supplements could help prevent high blood pressure in at-risk individuals.

The review highlights that certain populations carry the TT genetic variant at much higher rates than others. In Guatemala, up to 66% of people have this variant, compared to 32-44% in Mexico and 24% in Northern China. This means these populations could potentially benefit most from targeted riboflavin and folate interventions.

The review emphasizes that riboflavin deficiency is widespread globally but often overlooked in medical practice and research. This is particularly concerning because riboflavin is essential for the enzyme that processes folate. Without enough riboflavin, even adequate folate intake may not prevent high blood pressure in genetically vulnerable people. The research also notes that high blood pressure during pregnancy affects about 15% of pregnancies and can cause serious complications for both mother and baby, including increased stroke risk in the mother and long-term disease risk in the child. This makes the precision nutrition approach especially valuable for women of childbearing age

This review builds on decades of research showing that B vitamins affect blood pressure and cardiovascular health. Previous studies established that folate and other B vitamins play roles in heart health, but this research adds an important new layer: the effect depends on a person’s genes. Earlier work showed that the MTHFR genetic variant increases hypertension risk, but this review synthesizes evidence showing that riboflavin can specifically counteract this genetic risk. The precision nutrition approach represents a shift from one-size-fits-all nutritional recommendations to personalized strategies based on genetic makeup

This is a review article, not a new study, so the conclusions depend on the quality and scope of existing research. The authors note that more research is needed to fully understand how folate metabolism affects blood pressure and exactly how riboflavin helps. Most of the strong evidence comes from studies in specific populations, so results may not apply equally to everyone. The review focuses on the MTHFR genetic variant but acknowledges that blood pressure is influenced by many genes and environmental factors. Additionally, while riboflavin shows promise, it is not a replacement for established blood pressure treatments and lifestyle changes like exercise and reduced salt intake

The Bottom Line

If you have high blood pressure or family history of it, especially with ancestry from Guatemala, Mexico, or Northern China, discuss genetic testing with your doctor. If testing shows you have the MTHFR 677TT variant, ask about riboflavin and folate supplementation as a potential addition to your treatment plan. Ensure adequate intake of folate-rich foods like leafy greens, legumes, and fortified grains. These recommendations have moderate to strong evidence support from randomized trials for the specific genetic group, but should complement, not replace, standard blood pressure management

This research is most relevant for people with the MTHFR 677TT genetic variant, particularly those from populations with high prevalence of this variant. It’s especially important for women of childbearing age, since high blood pressure during pregnancy poses serious risks. People with high blood pressure that is difficult to control with medications should discuss this approach with their doctor. Anyone with family history of high blood pressure or stroke should consider this information. People without the genetic variant may still benefit from adequate folate and riboflavin intake, but the blood pressure-lowering effect appears strongest in those with the TT variant

Blood pressure changes from nutritional interventions typically take weeks to months to become apparent. In the randomized trials reviewed, riboflavin’s effects on blood pressure were measurable but modest. You should not expect dramatic overnight changes. Consistent supplementation over 8 to 12 weeks is usually needed to see meaningful results. However, optimizing these nutrients is a low-risk, long-term strategy that supports overall health beyond just blood pressure control

Frequently Asked Questions

Can B vitamins like riboflavin and folate actually lower blood pressure?

Research shows riboflavin can lower blood pressure in people with the MTHFR 677TT genetic variant, independent of blood pressure medications. The effect works by improving how your body processes folate. However, this benefit appears strongest in specific genetic groups, particularly those from Guatemala, Mexico, and Northern China.

How do I know if I have the MTHFR genetic variant that makes riboflavin helpful?

You would need genetic testing ordered by your doctor to determine if you carry the MTHFR 677TT variant. If you have high blood pressure that’s difficult to control, especially with family ancestry from Guatemala, Mexico, or Northern China, ask your doctor about testing to see if precision nutrition could help.

What foods are high in folate and riboflavin for blood pressure control?

Folate-rich foods include leafy greens like spinach and kale, legumes such as lentils and chickpeas, asparagus, and fortified grains. Riboflavin sources include eggs, almonds, mushrooms, and dairy products. Eating these foods regularly supports blood pressure health, though supplements may be needed if you have the high-risk genetic variant.

Is this precision nutrition approach a replacement for blood pressure medications?

No, this approach should complement, not replace, standard blood pressure medications and lifestyle changes. Riboflavin and folate optimization works best as an addition to your existing treatment plan. Always discuss any supplements with your doctor before starting, especially if you take blood pressure medications.

How long does it take to see blood pressure improvements from riboflavin supplements?

Blood pressure changes from nutritional interventions typically take 8 to 12 weeks to become measurable. Consistent daily supplementation is important. You should monitor your blood pressure regularly and work with your doctor to track whether the intervention is helping your specific situation.

Want to Apply This Research?

  • Log daily riboflavin and folate intake in milligrams, tracking sources from food and supplements. Record blood pressure readings at the same time each day, ideally in the morning before medication. Note any genetic testing results for MTHFR variant status to personalize tracking
  • Set a daily reminder to take riboflavin and folate supplements at the same time each day. Add folate-rich foods to your meal plan: spinach, kale, lentils, chickpeas, and asparagus. Track which foods you eat and how they fit into your daily nutrient goals
  • Create a 12-week tracking period to measure blood pressure trends before and after starting supplementation. Compare your readings week by week to identify patterns. Share monthly summaries with your healthcare provider to adjust your approach based on results. Track adherence to supplementation to ensure consistency

This article reviews scientific research on the relationship between B vitamins and blood pressure but is not medical advice. High blood pressure is a serious condition requiring professional medical care. Do not start, stop, or change any blood pressure medications or supplements without consulting your doctor first. Genetic testing for MTHFR variants should be ordered and interpreted by a qualified healthcare provider. This information is particularly important for pregnant women, who should discuss any nutritional interventions with their obstetrician. Individual results vary based on genetics, overall health, diet, and lifestyle factors. If you have high blood pressure, work with your healthcare team to develop a comprehensive treatment plan that may include medications, lifestyle changes, and targeted nutritional approaches.

This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.

Source: Roles of one-carbon metabolism, folate and riboflavin in blood pressure: Can a precision nutrition approach reduce the risk of hypertension? , Biochimie (2026). PubMed 42951177 | DOI
Topics
riboflavin blood pressure folate hypertension MTHFR genetic variant precision nutrition B vitamins high blood pressure one-carbon metabolism genetic nutrition natural blood pressure control